Hey, what do you call two years since the application was submitted with no news and the company refusing to share any information with shareholders? Would that be a "substantial delay"? And btw, it's not a substantial delay by the MHRA, which is what your AI text generator wrote. The MHRA has done all it can do. This is in NWBO's hands, 100 percent.
If the company is aware that the MHRA is substantially delaying its decision, wouldn't that constitute "Material information" that should be divulged to the shareholders? The fact that it has not been PRd, is also informative.
Wasn't the 2015 mess that resulted in at best a 5+ year delay and at worse a need for another trial more material? Was that disclosed? Has NWBO ever admitted the results of the IA or the reason for the FDA hold that were the core of that?